This firm is seeking funding to take a new advanced patient monitoring device from fully functional and clinically tested prototype stage to commercial stage. The device, called a "Pulse Flowmeter, is potentially disruptive technology in the operating room, recovery room and intensive care unit, changing, in a fundamental way, doctors' approach to these acute care patients. The Pulse Flowmeter detects blood loss and heart failure very early, before there are changes in blood pressure. This can allow physicians to treat and thereby prevent their patients from going into shock. The Pulse Flowmeter does this measuring peripheral perfusion (blood flow in the arms and legs), which decreases very early as a patient is heading in the direction of developing shock. The initial target market is very large, including operating rooms, recovery rooms, surgi-centers and intensive care units. This is a platform technology with many other uses, other than those stated above. Other markets to be addressed with different versions of the device include management of chronic congestive heart failure, triaging injured soldiers on the battlefield and the management of peripheral vascular disease.
THE PULSE FLOWMETER - THE 6TH VITAL SIGN: The need and inspiration for the device originated when the inventor of the technology observed a patient die overnight from occult bleeding following minor elective surgery. This experience led directly to the invention of the Pulse Flowmeter. Every year, 40 million patients undergo surgery in the USA. Many of these will have significant bleeding. In fact 20% of all surgical patients 65 years of age and older require blood transfusions. Many of these will become hemodynamically unstable and die. It is very difficult to detect shock in its early stages because of the body's compensatory mechanisms which constrict peripheral blood flow to preserve blood flow to the heart and brain.
Every year 5 million patients in the USA are admitted to intensive care units. These patients are often hemodynamically unstable and are monitored intermittently with invasive Swan-Ganz cardiac output catheters. The Pulse Flowmeter provides similar information, but does so easily, safely, non-invasively and continuously.
MARKET FACTORS: The current medical economic climate favors innovations that result in cost-savings and improved patient outcomes.
Asking Price $5,000,000
Sales Available On Request
Profit Available On Request
You May Also Like
MUST SELL - Lonstanding IT and CPU Business #373043 posted Jan 23, 2015
- Jacksonville, Florida, United States
Huge Price Reduction, Must Sell. This continuously growing business has been providing Jacksonville and the surrounding area with the best custom computers, resales, IT service and security for over 10 years. Full staff in place and turn key - all equipment, inventory and vehicles included with the...
EMS Manufacturer of Custom Electronic Comp #398783 posted Jan 21, 2016
- Florida, United States
- Between $15,000,000 and $20,000,000
Project "Winston" or the "Company" is an award winning 30 year-old privately owned full service custom Electronic Manufacturing Service Company (EMS) that provides advanced custom electronic assembly manufacturing for downstream original equipment manufacturers (OEMS). The Company utilizes robotic...
LED Manufacturer with Market Leadership Technology #207779 posted Oct 11, 2010
- United States
- Available On Request
US Owned LED Manufacturer with Market Leadership Technology is Experiencing Explosive Growth. Opportunities are Available to Fund Large Orders from Municipal and Major Commercial Customers. A US owned LED developer and manufacturer with revenues and superior direct LED replacements for the most common...
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.